200 related articles for article (PubMed ID: 495512)
1. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
[TBL] [Abstract][Full Text] [Related]
2. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of prazosin effect on cardiac output in chronic heart failure.
Arnold SB; Williams RL; Ports TA; Baughman RA; Benet LZ; Parmley WW; Chatterjee K
Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164
[TBL] [Abstract][Full Text] [Related]
4. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.
Mehta J; Iacona M; Feldman RL; Pepine CJ; Conti CR
Am J Cardiol; 1978 May; 41(5):925-30. PubMed ID: 645603
[No Abstract] [Full Text] [Related]
5. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure.
Good AP; Unverferth DV; Leier CV
Cardiovasc Drugs Ther; 1988 Jan; 1(5):529-34. PubMed ID: 2908715
[TBL] [Abstract][Full Text] [Related]
7. Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure.
Feldman RC; Ball RM; Winchester MA; Jaillon P; Kates RE; Harrison DC
Am Heart J; 1981 May; 101(5):534-40. PubMed ID: 7223593
[TBL] [Abstract][Full Text] [Related]
8. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
[TBL] [Abstract][Full Text] [Related]
9. Use of oral prazosin hydrochloride in congestive failure following acute myocardial infarction.
Lopez-Sendon J; Coma-Canella I; Lombera F; Jadraque LM
Am Heart J; 1979 Oct; 98(4):495-504. PubMed ID: 484435
[TBL] [Abstract][Full Text] [Related]
10. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
Elkayam U; Lejemtel TH; Mathur M; Ribner HS; Frishman WH; Strom J; Sonnenblick EH
Am J Cardiol; 1979 Sep; 44(3):540-5. PubMed ID: 474434
[No Abstract] [Full Text] [Related]
11. Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.
Greenberg BH; Massie BM
Circulation; 1980 Jun; 61(6):1212-6. PubMed ID: 7371134
[No Abstract] [Full Text] [Related]
12. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
Olivari MT; Levine TB; Cohn JN
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
[TBL] [Abstract][Full Text] [Related]
13. Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy.
Awan NA; Lee G; DeMaria AN; Mason DT
Am Heart J; 1981 May; 101(5):541-7. PubMed ID: 7223594
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive radiocardiographic assessment of the effects of prazosin in congestive heart failure.
Nakajima H; Yui Y; Kawashita K; Yoshida A; Kawai C
Jpn Circ J; 1982 May; 46(5):468-72. PubMed ID: 7077811
[TBL] [Abstract][Full Text] [Related]
15. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
Miller RR; Awan NA; Maxwell KS; Mason DT
N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
[TBL] [Abstract][Full Text] [Related]
17. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
Elkayam U; Mathur M; Frishman W; LeJemtel T; Strom J; Sonnenblick EH
Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
Hayashi H; Sassa H; Oba M; Fukaya T; Okubo M; Niwa T; Matsui E
Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
[TBL] [Abstract][Full Text] [Related]
20. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
Bertel O; Burkart F; Bühler FR
Am Heart J; 1981 May; 101(5):529-33. PubMed ID: 7223592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
